Ann Dermatol.  2013 Nov;25(4):498-500. 10.5021/ad.2013.25.4.498.

Elevated KAI1 Protein Expression Identified in Malignant Melanoma

• Cho MK

• KMID: 2265072
• DOI: http://doi.org/10.5021/ad.2013.25.4.498

Abstract

No abstract available.

MeSH Terms

Antigens, CD82*
Melanoma*
Antigens, CD82

Figure

• 

  Fig. 1 (A) KAI1/CD82 protein was expressed on malignant melanoma by western blot analysis. (B) The score of relative KAI1/CD82 protein expression. Normal: normal skin, MM: malignant melanoma, SCC: squamous cell carcinoma, BCC: basal cell carcinoma.

• 

  Fig. 2 Representative immunohistochemistry staining for KAI1/CD82 protein expression in paraffin-embedded malignant melanoma (A: strongly positive immunostaining, ×200), squamous cell carcinoma (B: very weakly positive immunostaining, ×200), basal cell carcinoma (C: very weakly positive immunostaining, ×200) and normal skin (D: no immunostaining, ×100).

Reference

1. Dong JT, Isaacs WB, Barrett JC, Isaacs JT. Genomic organization of the human KAI1 metastasis-suppressor gene. Genomics. 1997; 41:25–32.

2. Chen Z, Mustafa T, Trojanowicz B, Brauckhoff M, Gimm O, Schmutzler C, et al. CD82, and CD63 in thyroid cancer. Int J Mol Med. 2004; 14:517–527.

3. Hinoda Y, Adachi Y, Takaoka A, Mitsuuchi H, Satoh Y, Itoh F, et al. Decreased expression of the metastasis suppressor gene KAI1 in gastric cancer. Cancer Lett. 1998; 129:229–234.

4. Guo XZ, Friess H, Maurer C, Berberat P, Tang WH, Zimmermann A, et al. KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers. Cancer Res. 1998; 58:753–758.

5. Yusenko MV, Kovacs G. Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma. Histopathology. 2009; 55:687–695.

6. Geradts J, Maynard R, Birrer MJ, Hendricks D, Abbondanzo SL, Fong KM, et al. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues. Am J Pathol. 1999; 154:1665–1671.

7. Farhadieh RD, Smee R, Ow K, Yang JL, Russell PJ, Crouch R, et al. Down-regulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival. Cancer Lett. 2004; 213:91–98.

8. Okochi H, Kato M, Nashiro K, Yoshie O, Miyazono K, Furue M. Expression of tetra-spans transmembrane family (CD9, CD37, CD53, CD63, CD81 and CD82) in normal and neoplastic human keratinocytes: an association of CD9 with alpha 3 beta 1 integrin. Br J Dermatol. 1997; 137:856–863.